Chronic mild stress accelerates the progression of Parkinson's disease in A53T α-synuclein transgenic mice

被引:37
|
作者
Wu, Qimei [1 ]
Yang, Xiaoyu [1 ]
Zhang, Yu [1 ]
Zhang, Lei [1 ]
Feng, Linyin [1 ]
机构
[1] Chinese Acad Sci, Shanghai Inst Mat Med, CAS Key Lab Receptor Res, 555 Chong Zhi Rd, Shanghai 201203, Peoples R China
关键词
Chronic mild stress; Parkinson's disease; alpha-synuclein; Dopamine; Microglia; INDUCED NEUROTOXICITY; DOPAMINERGIC-NEURONS; CORTISOL RELEASE; SEX-DIFFERENCES; MOUSE MODEL; BRAIN; ONSET; NEURODEGENERATION; ACTIVATION; MICROGLIA;
D O I
10.1016/j.expneurol.2016.09.004
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Daily stress is associated with increased risk for various diseases, and numerous studies have provided evidence that environmental stress leads to deleterious effects on the central nervous system. However, it remains unclear whether chronic stress exacerbates the progression of Parkinson's disease (PD). To investigate this hypothesis, we determined the effect of chronic mild stress (CMS) on the pathogenesis of PD in a transgenic mice line that overexpresses the human A53T mutant alpha-synuclein (A53T Tg mice). We show that when exposed to CMS, male, but not female, A53TTg mice developed profound motor disabilities and exhibited olfactory sensitivity deficits. Pathological analysis also identified robust dopaminergic neuron degeneration and strong reduction of dopamine levels in A53T Tg male mice who underwent CMS treatment. Systematic examination of the abnormal aggregation of a-synuclein revealed a profound increase of inclusion in A53TTg male mice subject to CMS resembling key pathological changes of PD. An insight into the mechanism underlying stress leading to the acceleration of neurodegeneration in those with generic susceptibility, was revealed by evidence of microglia activation and elevated pro-inflammatory factor levels in A53T Tg male mice following CMS. Notably, these effects of CMS on the pathogenesis of PD showed a remarkable sexual dimorphism: only male A53T Tg mice exhibited exacerbation of the progression of PD. However, the molecular and cellular bases for this difference remains to be elucidated. Our results indicate a causative role for chronic mild stress using a PD animal model. Based on these findings, we propose that CMS acts as an environmental risk factor that leads to neuroinflammation and progressive neurodegeneration on a background of PD susceptibility. (C) 2016 Elsevier Inc. All rights reserved.
引用
收藏
页码:61 / 71
页数:11
相关论文
共 50 条
  • [1] Longitudinal Metabolomics Profiling of Parkinson's Disease-Related α-Synuclein A53T Transgenic Mice
    Chen, Xi
    Xie, Chengsong
    Sun, Lixin
    Ding, Jinhui
    Cai, Huaibin
    PLOS ONE, 2015, 10 (08):
  • [2] Astrocytic expression of Parkinson's disease-related A53T α-synuclein causes neurodegeneration in mice
    Gu, Xing-Long
    Long, Cai-Xia
    Sun, Lixin
    Xie, Chengsong
    Lin, Xian
    Cai, Huaibin
    MOLECULAR BRAIN, 2010, 3
  • [3] Effects of Ginkgo Biloba Extract on A53T α-Synuclein Transgenic Mouse Models of Parkinson's Disease
    Kuang, Shaosong
    Yang, Lin
    Rao, Ziliang
    Zhong, Zhiyong
    Li, Jinfeng
    Zhong, Haichao
    Dai, Lulu
    Tang, Xiaojiang
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 2018, 45 (02) : 182 - 187
  • [4] Neurodegeneration by α-synuclein-specific T cells in AAV-A53T-α-synuclein Parkinson's disease mice
    Karikari, Akua A.
    McFleder, Rhonda L.
    Ribechini, Eliana
    Blum, Robert
    Bruttel, Valentin
    Knorr, Susanne
    Gehmeyr, Mona
    Volkmann, Jens
    Brotchie, Jonathan M.
    Ahsan, Fadhil
    Haack, Beatrice
    Monoranu, Camelia-Maria
    Keber, Ursula
    Yeghiazaryan, Rima
    Pagenstecher, Axel
    Heckel, Tobias
    Bischler, Thorsten
    Wischhusen, Joerg
    Koprich, James B.
    Lutz, Manfred B.
    Ip, Chi Wang
    BRAIN BEHAVIOR AND IMMUNITY, 2022, 101 : 194 - 210
  • [5] Alpha-Synuclein-Specific Regulatory T Cells Ameliorate Parkinson's Disease Progression in Mice
    Park, Seon-Young
    Yang, Hyejin
    Kim, Soyoung
    Yang, Juwon
    Go, Hyemin
    Bae, Hyunsu
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (20)
  • [6] Glucocerebrosidase haploinsufficiency in A53T α-synuclein mice impacts disease onset and course
    Tayebi, Nahid
    Parisiadou, Loukia
    Berhe, Bahafta
    Gonzalez, Ashley N.
    Serra-Vinardell, Jenny
    Tamargo, Raphael J.
    Maniwang, Emerson
    Sorrentino, Zachary
    Fujiwara, Hideji
    Grey, Richard J.
    Hassan, Shahzeb
    Blech-Hermoni, Yotam N.
    Chen, Chuyu
    McGlinchey, Ryan
    Makariou-Pikis, Chrissy
    Brooks, Mieu
    Ginns, Edward I.
    Ory, Daniel S.
    Giasson, Benoit I.
    Sidransky, Ellen
    MOLECULAR GENETICS AND METABOLISM, 2017, 122 (04) : 198 - 208
  • [7] Age-dependent neurodegeneration and neuroinflammation in a genetic A30P/A53T double-mutated α-synuclein mouse model of Parkinson's disease
    Rauschenberger, Lisa
    Behnke, Jennifer
    Grotemeyer, Alexander
    Knorr, Susanne
    Volkmann, Jens
    Ip, Chi Wang
    NEUROBIOLOGY OF DISEASE, 2022, 171
  • [8] Levodopa Rescues Retinal Function in the Transgenic A53T Alpha-Synuclein Model of Parkinson's Disease
    Tran, Katie K. N.
    Wong, Vickie H. Y.
    Vessey, Kirstan A.
    Finkelstein, David I.
    Bui, Bang V.
    Nguyen, Christine T. O.
    BIOMEDICINES, 2024, 12 (01)
  • [9] Fibrillization of α-synuclein and tau in familial Parkinson's disease caused by the A53T α-synuclein mutation
    Kotzbauer, PT
    Giasson, BI
    Kravitz, AV
    Golbe, LI
    Mark, MH
    Trojanowski, JQ
    Lee, VMY
    EXPERIMENTAL NEUROLOGY, 2004, 187 (02) : 279 - 288
  • [10] Benzo(a)pyrene exposure in utero exacerbates Parkinson's Disease (PD)-like α-synucleinopathy in A53T human alpha-synuclein transgenic mice
    Xu, Weixing
    Qi, Yuze
    Gao, Yanjun
    Quan, Huihui
    Li, Qingru
    Zhou, Hui
    Huang, Jing
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2021, 427